Thrombotic risk in stable atherosclerotic disease

Organized with the support of Bayer

Vendredi 19 Janvier 2018   14:00-15:30   Bordeaux Amphitheatre
Sponsored main session (organized with the support of Industry)
Rationale for an antithrombotic therapy
Aspirin, yes... but
Denis Angoulvant
14:40 • Denis Angoulvant
What's new since CAPRIE?
15:00 • Victor Aboyans
What about anticoagulation?